- Cancer Biology & Biomarkers
- Chromatography & Mass Spectrometry
- Contract Research, Clinical Trials and Outsourcing
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & RMMs
- NIR, PAT & QbD
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
- Events & Workshops
BioTek introduces Synergy Neo2 high performance Multi-Mode Microplate Reader
14 October 2015 • Author: BioTek
BioTek announces the release of the new Synergy Neo2 Multi-Mode Reader. With improved performance and new features, Synergy Neo2 is now the most advanced, high-performance, high-speed plate reader on the market.
Synergy™ Neo2 is designed for speed and ultra high performance, incorporating BioTek’s patented Hybrid Technology™, with its independent optical paths that ensure uncompromised performance. Continuously variable bandwidth quadruple monochromators, sensitive high transmission filter-based optics and up to 4 PMTs provide ultra-fast measurements with excellent results. Advanced environment controls, including CO2/O2 control, incubation to 65 °C and variable shaking support live cell assays; cell-based detection is optimized with direct bottom illumination. Barcode-labeled filter cubes help streamline workflows and limit errors, and the available BioStackNeo plate stacker is the fastest on the market – ideal for high throughput requirements. Powerful Gen5™ Data Analysis Software is included, and features designed for 21 CFR Part 11 compliance are available in Gen5 Secure.
Gary Barush, Director of Marketing & Sales, states “For years BioTek has led the evolution of multi-mode detection. We are proud to introduce this top-of-the-line reader which combines best in class performance in all modes with the speed that customers demand. In addition to being optimized for biochemical assay performance, Synergy Neo2 provides unsurpassed results for cell based assay detection, while its modular configuration makes this new level of performance accessible for many budgets.”
BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. These technologies are used to aid life science research, facilitate drug discovery, provide rapid and cost-effective analysis, and enable sensitive, accurate quantification of molecules across diverse applications. BioTek espouses a “Think Possible” approach that sets the tone for fresh ideas, unsurpassed customer service and original innovations. The company is frequently honored for local accomplishments and technological innovations, including Best Places to Work in Vermont, Frost & Sullivan North American New Product Innovation Award for Workflow Solutions in Life Sciences, SelectScience’s Drug Discovery Product of the Year – Scientists’ Choice Award, and a Silver Edison Award for the Cytation Cell Imaging Multi-Mode Reader.
ABB Analytical Measurement ACD/Labs ADInstruments Ltd Advanced Analytical Technologies GmbH Analytik Jena AG Astell Scientific Ltd B&W Tek Bachem AG Bibby Scientific Limited Bio-Rad Laboratories BioNavis Ltd Biopharma Group Black Swan Analysis Limited Charles Ischi AG | Kraemer Elektronik Cherwell Laboratories CI Precision Cobalt Light Systems Coulter Partners CPC Biotech srl Dassault Systèmes BIOVIA DiscoverX Edinburgh Instruments Enterprise System Partners (ESP) EUROGENTEC F.P.S. Food and Pharma Systems Srl IDBS JEOL Europe L.B. Bohle Maschinen + Verfahren GmbH Lab M Ltd. LabWare Linkam Scientific Instruments Limited Molins Technologies Multicore Dynamics Ltd Nanosurf New England Biolabs, Inc. Panasonic Biomedical Sales Europe B.V. PerkinElmer Inc ReAgent Russell Finex Limited Source BioScience Takara Clontech Tornado Spectral Systems Tuttnauer Watson-Marlow Fluid Technology Group Wickham Laboratories Limited Xylem Analytics YMC Europe GmbH Yusen Logistics